West Virginia University Hospitals, Inc.
Mary Babb Randolph Cancer Center
Section of Hematology/Oncology
1 Medical Center Drive, PO Box 8110
Morgantown, WV 26506-8110
Direct phone: (304) 598-4520
Total transplants by cell source
- Marrow: 11
- PBSC: 32
- Cord Blood: 9
- Autologous (PBSC or Marrow): 79
About the center
Adult autologous and allogeneic stem cell transplants, with active protocols for myeloablative, non-myeloablative and reduced intensity transplants, non-myeloablative and myeloablative cord protocols and haploidentical transplants. Limited pediatric patients (ages 16 to 18): autologous for Hodgkin's disease protocol and related allogeneic for aplastic anemia . CAR-T cell therapy for the diagnosis of ALL for 18-25 year old patients and NHL and we also offer CAR-T for Mantle Cell lymphoma, Follicular Lymphoma, and Multiple Myeloma.
This center has been performing allogeneic transplants since 1992 and has been an NMDP/Be The Match transplant center since June 1997.
Adult - Michael Craig, Abraham Kanate, Kelly Ross, Lauren Veltri
Marrow/PBSC, single cord, and double cord
Cord blood transplants performed on
Other programs and services
We have Rosenbaum Family House that provides discounted housing for our patients and families during treatment and transplant. We have patient and caregiver support groups that meet on campus. Nutrition and Chaplin support are available in clinic.
Overall center survival
Patient survival information for this center
This center's actual 1-year survival results are similar to the expected rate for this center.
The survival information we have for this center includes ONLY:
- Patients who had their FIRST ALLOGENEIC transplant (cells from a related or unrelated donor/cord blood) during 2017, 2018, 2019, and
- Who had their transplant at a U.S. transplant center, and
- Who had follow-up information provided by the transplant center for analysis
For this center, we have survival information for 72 patients.
The actual 1-year survival of these patients is 66.7%.
Compared to similar patients transplanted at all centers in the U.S., we expect that the 1-year survival for patients at this center to be in a range between 60.7% and 80.7%.
For help with understanding these statistics, please see Understanding Transplant Outcomes.
For overall survival for all patients transplanted with a specific disease, please see U.S. Patient Survival report at bloodcell.transplant.hrsa.gov.
Transplants reported (From January 1, 2019 to December 31st, 2020 as reported by the centers)
|Both marrow & PBSC
Transplants by disease
Number of transplants by age reported from January 1, 2019 to December 31st, 2020 (includes marrow, PBSC and cord blood)
Treatments may be similar for diseases within a group. It might be helpful to look at centers that have done transplants for a specific disease and centers that have done transplants for any corresponding broad disease categories.
Centers are not required to report autologous transplants so the numbers might be incomplete.
More information about transplants for this disease can be found:
Transplant center resources
Transplant center coordinator:
(304) 598-4000 (ext 72455)
Be The Match patient navigators
Patient navigators can answer your questions about choosing a transplant center and provide support and education to help you throughout your transplant journey.
Inside the United States: 1 (888) 999-6743
Outside the United States: 1 (763) 406-3410.
(Long distance or international charges may apply.)
No survivorship program information is available. Contact the center for information about post-transplant care.